Caxton Associates (New York)’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-8,563
Closed -$347K – 543
2019
Q4
$347K Buy
+8,563
New +$319K 0.05% 248

Other funds holding PBH

Caxton Associates (New York)'s PBH Position: Q1 2020 in Review

Caxton Associates (New York) sold out of Prestige Consumer Healthcare (PBH) in Q1 2020, closing a stake of 8,563 shares — an estimated $347K sold.

Caxton Associates (New York) first reported a position in PBH in Q4 2019 and held it in 1 quarter. The position peaked at $347K in Q4 2019. 250 funds tracked by Wall St. Rank hold PBH as of Q1 2020.

  • Caxton Associates (New York) reported no remaining Prestige Consumer Healthcare position as of Q1 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 8,563 Prestige Consumer Healthcare shares in Q1 2020, an estimated $347K.
  • Caxton Associates (New York) first reported a position in Prestige Consumer Healthcare in Q4 2019 and held it in 1 quarter.
  • Caxton Associates (New York)'s Prestige Consumer Healthcare position peaked at $347K in Q4 2019.
  • 250 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2020.

Based on Caxton Associates (New York)'s 13F filing for Q1 2020, filed 15 May 2020.